Last update 08 May 2025

Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy(Shengyan Pharmaceutical Technology)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy, BCMA-CD38 Bispecific CAR-Modified T Cells, BCMA-CD38 bispecific CAR-T cells
+ [1]
Target
BCMA x CD38
Action
modulators
Mechanism
BCMA modulators(B-cell maturation protein modulators), CD38 modulators(Lymphocyte differentiation antigen CD38 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [1]
Active Indication
Multiple Myeloma
Inactive Indication-
Originator Organization
Shanghai Shengyan Pharmaceutical Technology Development Co., Ltd.
Active Organization
Shanghai Shengyan Pharmaceutical Technology Development Co., Ltd.Wuhan Xiehe Hospital Tower
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy(Shengyan Pharmaceutical Technology)
Login to view more data
100 Translational Medicine associated with Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy(Shengyan Pharmaceutical Technology)
Login to view more data
100 Patents (Medical) associated with Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy(Shengyan Pharmaceutical Technology)
Login to view more data
100 Deals associated with Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy(Shengyan Pharmaceutical Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 1-
Shanghai Shengyan Pharmaceutical Technology Development Co., Ltd.
-
Multiple MyelomaPhase 1
China
Wuhan Xiehe Hospital Tower
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free